ASSESSMENT OF HISTOLOGICAL REMISSION IN PATIENTS TREATED WITH FILGOTINIB BY DIFFERENT SCORES AND CONCORDANCE WITH ENDOSCOPIC AND HEALTH-RELATED QUALITY OF LIFE OUTCOMES: POST HOC ANALYSIS FROM THE SELECTION STUDY

Fernando Magro  ¹     Laurent Peyrin-Biroulet  ²     Gerhard Rogler  ³     Haridarshan Patel  ⁴     Angela de Haas  ⁵     Eva Santermans  ⁵     Haoyao Ruan  ⁶     Louis Dron  ⁷     Brian G. Feagan  ^8    
1 University of Porto, Porto, Porto, Portugal
² University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France
³ University of Zurich, Zurich, Switzerland
⁴ Galapagos NV, Mechelen, Belgium
⁵ Galapagos NV, Leiden, Netherlands
⁶ Cytel, Toronto, Canada
⁷ Cytel, Vancouver, Canada
⁸ Western University, London, Canada

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)